We are live on ! Find out more
FL

Fort LP Portfolio holdings

AUM $39.6M
1-Year Est. Return 37.11%
This Fund
S&P 500
This Quarter Est. Return
+7.71%
1 Year Est. Return
+37.11%
3 Year Est. Return
+56.81%
5 Year Est. Return
+128.28%
10 Year Est. Return
+343.79%
AUM
$239M
AUM Growth
+$53.9M
Cap. Flow
+$41.7M
Cap. Flow %
17.47%
Top 10 Hldgs %
6.49%
Holding
318
New
49
Increased
177
Reduced
69
Closed
23

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$738K
2
CI icon
Cigna
CI
+$716K
3
SLGN icon
Silgan Holdings
SLGN
+$709K
4
BIIB icon
Biogen
BIIB
+$671K
5
MOH icon
Molina Healthcare
MOH
+$671K

Sector Composition

Rank Sector Weight
1 Technology 25.16%
2 Healthcare 21.16%
3 Industrials 19.58%
4 Consumer Staples 13.33%
5 Consumer Discretionary 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
76
Medtronic
MDT
$106B
$1.18M 0.5%
11,368
+2,130
+23% +$214K
HUM icon
77
Humana
HUM
$48B
$1.18M 0.49%
2,849
+1,341
+89% +$539K
YUM icon
78
Yum! Brands
YUM
$40.8B
$1.18M 0.49%
12,918
+2,969
+30% +$274K
PFE icon
79
Pfizer
PFE
$143B
$1.18M 0.49%
33,812
+5,704
+20% +$200K
MRK icon
80
Merck
MRK
$315B
$1.17M 0.49%
14,819
+2,673
+22% +$209K
JKHY icon
81
Jack Henry & Associates
JKHY
$10.8B
$1.17M 0.49%
7,199
+903
+14% +$157K
CDK
82
DELISTED
CDK Global, Inc.
CDK
$1.16M 0.49%
26,709
+4,978
+23% +$221K
HD icon
83
Home Depot
HD
$338B
$1.16M 0.49%
4,175
+397
+11% +$108K
IBM icon
84
IBM
IBM
$200B
$1.16M 0.49%
9,953
+2,047
+26% +$241K
LDOS icon
85
Leidos
LDOS
$13.4B
$1.15M 0.48%
12,943
+2,084
+19% +$188K
GNTX icon
86
Gentex
GNTX
$5.19B
$1.15M 0.48%
44,720
+7,862
+21% +$209K
KO icon
87
Coca-Cola
KO
$351B
$1.15M 0.48%
23,315
+4,919
+27% +$237K
OTEX icon
88
Open Text
OTEX
$5.65B
$1.14M 0.48%
27,027
+3,945
+17% +$173K
DOV icon
89
Dover
DOV
$28.8B
$1.14M 0.48%
10,516
+1,334
+15% +$143K
PM icon
90
Philip Morris
PM
$301B
$1.13M 0.47%
15,055
+2,629
+21% +$203K
WDFC icon
91
WD-40
WDFC
$3.31B
$1.13M 0.47%
5,964
+840
+16% +$165K
FFIV icon
92
F5
FFIV
$23.1B
$1.13M 0.47%
9,178
+1,732
+23% +$233K
EXPO icon
93
Exponent
EXPO
$3.05B
$1.13M 0.47%
15,629
+2,174
+16% +$173K
K
94
DELISTED
Kellanova
K
$1.12M 0.47%
18,512
+5,965
+48% +$378K
CTSH icon
95
Cognizant
CTSH
$21.2B
$1.12M 0.47%
16,138
+3,985
+33% +$259K
VRTX icon
96
Vertex Pharmaceuticals
VRTX
$123B
$1.12M 0.47%
4,108
+2,006
+95% +$553K
WU icon
97
Western Union
WU
$2.77B
$1.12M 0.47%
52,065
+8,556
+20% +$194K
BKNG icon
98
Booking.com
BKNG
$141B
$1.11M 0.47%
16,300
+3,525
+28% +$248K
ALLE icon
99
Allegion
ALLE
$11.8B
$1.11M 0.47%
11,240
+2,019
+22% +$205K
JNPR
100
DELISTED
Juniper Networks
JNPR
$1.11M 0.47%
51,724
+9,465
+22% +$224K

Similar funds

Fort LP's Q3 2020 Portfolio in Review

As of Q3 2020, Fort LP held 318 positions worth $239M, up 29% from $185M the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

Fort LP deployed $41.7M of net new capital in Q3 2020, opening 49 new positions and adding to 177 existing holdings. Its largest new stake was Neurocrine Biosciences: 6,378 shares worth $613K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Cable One, an estimated $377K trimmed.

  • Fort LP's largest Q3 2020 buy was Neurocrine Biosciences: 6,378 shares worth $613K.
  • Fort LP added most to Vertex Pharmaceuticals in Q3 2020, an estimated $553K increase.
  • Fort LP's biggest Q3 2020 reduction was Cable One, cutting an estimated $377K.
  • Fort LP fully exited Paramount Global Class B in Q3 2020, selling an estimated $547K.
  • Fort LP's ten largest holdings make up 6.5% of its $239M portfolio in Q3 2020.
  • Fort LP opened 49 new positions and closed 23 in Q3 2020.
  • Fort LP's portfolio value rose 29% quarter-over-quarter to $239M.

Based on Fort LP's 13F filing for Q3 2020, filed 13 Nov 2020.